These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

80 related articles for article (PubMed ID: 969008)

  • 1. [Apomorphine treatment of withdrawal symptoms in young opiate addicts].
    Gulmann NC; Kaldan B; Kobbernagal F
    Ugeskr Laeger; 1976 Oct; 138(42):2547-50. PubMed ID: 969008
    [No Abstract]   [Full Text] [Related]  

  • 2. [Apomorphine in opiate withdrawal treatment].
    Hedri A
    Schweiz Rundsch Med Prax; 1972 Apr; 61(15):488-9. PubMed ID: 5022281
    [No Abstract]   [Full Text] [Related]  

  • 3. [Treatment of withdrawal syndrome with apomorphine].
    Ziegler B; Schneider E
    Arzneimittelforschung; 1974 Aug; 24(8):1117-9. PubMed ID: 4479363
    [No Abstract]   [Full Text] [Related]  

  • 4. [Therapy of withdrawal symptoms in "fixers". (Drug abuse of adolescents by intravenous injection)].
    Amitai M; Dickhaut HH; Hasenknopf P
    Nervenarzt; 1972 Mar; 43(3):157-60. PubMed ID: 5023740
    [No Abstract]   [Full Text] [Related]  

  • 5. [Clonidine in opiate abstinence].
    Maurset A; Bratfors O
    Tidsskr Nor Laegeforen; 1979 May; 99(15):791-2. PubMed ID: 462445
    [No Abstract]   [Full Text] [Related]  

  • 6. Treatment of alcohol withdrawal symptoms.
    Mayne DG
    Br J Hosp Med; 1982 Jul; 28(1):102. PubMed ID: 7126967
    [No Abstract]   [Full Text] [Related]  

  • 7. [Fractionated opiate withdrawal with tiapride and naloxone, a new treatment approach].
    Presslich O; Loimer N; Aschauer G; Fodor G; Pfersmann D; Müller K; Pakesch G; Lieber A
    Psychiatr Prax; 1989 Sep; 16(5):179-81. PubMed ID: 2798589
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Drug addiction. Medicosocial aspects].
    Fournier E; Piva C
    Maroc Med; 1972; 52(560):465-95. PubMed ID: 4563667
    [No Abstract]   [Full Text] [Related]  

  • 9. Dopamine agonist withdrawal syndrome: the apomorphine solution.
    Schlesinger I; Erikh I; Zaaroor M
    Arch Neurol; 2010 Sep; 67(9):1155; author reply 1156. PubMed ID: 20837868
    [No Abstract]   [Full Text] [Related]  

  • 10. Behavioral activation induced by D(2)-like receptor stimulation during opiate withdrawal.
    Druhan JP; Walters CL; Aston-Jones G
    J Pharmacol Exp Ther; 2000 Aug; 294(2):531-8. PubMed ID: 10900229
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The calcium channel antagonist nifedipine causes confusion when used to treat opiate withdrawal in morphine-dependent patients.
    Silverstone PH; Attenburrow MJ; Robson P
    Int Clin Psychopharmacol; 1992 Nov; 7(2):87-90. PubMed ID: 1487626
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Clonidine for opiate withdrawal.
    Channabasavanna SM; Subrahmanya M
    Lancet; 1981 Aug; 2(8241):313-4. PubMed ID: 6114361
    [No Abstract]   [Full Text] [Related]  

  • 13. [Methadone treatment in opiate addiction].
    Hess JP
    Harefuah; 1972 Aug; 83(4):160-1. PubMed ID: 5083977
    [No Abstract]   [Full Text] [Related]  

  • 14. [Use of clonidine in the treatment of opiate withdrawal syndrome].
    Bela M; Kiejna A; Krakiewicz A; Leszek J
    Wiad Lek; 1986 May; 39(10):683-7. PubMed ID: 3765630
    [No Abstract]   [Full Text] [Related]  

  • 15. [Behavior pattern of young opiate addicts in comparison with classical morphinists].
    Dieckhöfer K
    Nervenarzt; 1974 Mar; 45(3):142-6. PubMed ID: 4598803
    [No Abstract]   [Full Text] [Related]  

  • 16. [Peridural morphine in opiate addicts].
    Villalonga A; Castillo J; Hernández C; Nalda MA
    Med Clin (Barc); 1985 Nov; 85(17):729-30. PubMed ID: 3841380
    [No Abstract]   [Full Text] [Related]  

  • 17. Clonidine and opiate withdrawal.
    Lipman JJ; Spencer PS
    Lancet; 1978 Sep; 2(8088):521. PubMed ID: 79884
    [No Abstract]   [Full Text] [Related]  

  • 18. Pharmacological approaches to the treatment of morphine-type dependence.
    Halbach H
    Int J Clin Pharmacol Biopharm; 1975 Jul; 12(1-2):6-12. PubMed ID: 1165143
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The short- and long-termed effects of beta-endorphin on the opiate abstinence syndrome in rats.
    Haracz JL; Tseng LF
    Commun Psychopharmacol; 1980; 4(3):219-24. PubMed ID: 6262008
    [No Abstract]   [Full Text] [Related]  

  • 20. Mianserin and trazodone significantly attenuate the intensity of opioid withdrawal symptoms in mice.
    Schreiber S; Backler MM; Herman I; Shamir D; Rigai T; Bar-Hamburger R; Pick CG
    Addict Biol; 2003 Mar; 8(1):107-14. PubMed ID: 12749364
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 4.